The Scientist

» ebola and developmental biology

Most Recent

image: Contributors

Contributors

By | April 1, 2015

Meet some of the people featured in the April 2015 issue of The Scientist.

0 Comments

image: From Many, One

From Many, One

By | April 1, 2015

Diverse mammals, including humans, have been found to carry distinct genomes in their cells. What does such genetic chimerism mean for health and disease?

4 Comments

image: Ebola Mutation Rate Quibble

Ebola Mutation Rate Quibble

By | March 27, 2015

A study suggests that the virus may not be evolving as quickly as a previous group estimated.

0 Comments

image: Ebola Vax Trial Update

Ebola Vax Trial Update

By | March 26, 2015

A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 trial.

0 Comments

image: Short, Strong Signals

Short, Strong Signals

By | March 25, 2015

Methylation increases both the activity and instability of the signaling protein Notch.

0 Comments

image: WHO: Ramp Up Vaccination

WHO: Ramp Up Vaccination

By | March 23, 2015

The World Health Organization is calling for an increase in routine vaccinations for measles and other preventable diseases in Ebola-affected countries.

0 Comments

image: Elevated Measles Risk in Ebola-Stricken Regions

Elevated Measles Risk in Ebola-Stricken Regions

By | March 13, 2015

Decreased vaccination rates could lead to a deadlier measles outbreak, according to a study.

0 Comments

image: Rapid Ebola Test Approved

Rapid Ebola Test Approved

By | February 24, 2015

The World Health Organization OKs the first 15-minute Ebola diagnostic test.

0 Comments

image: Ebola Victims Still Infectious a Week After Death

Ebola Victims Still Infectious a Week After Death

By | February 12, 2015

Ebola virus can remain infectious for up to seven days on the bodies of monkeys that died from the disease, researchers show.

0 Comments

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

Advertisement
BD Biosciences
BD Biosciences

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
Lexogen
Lexogen
Advertisement
Life Technologies